Anda belum login :: 23 Nov 2024 07:29 WIB
Detail
ArtikelDetection of Interleukin-33 in Serum and Carcinoma Tissue from Patients with Hepatocellular Carcinoma and its Clinical Implications  
Oleh: Zhang, P. ; Liu, X-K. ; Chu, Z. ; Ye, J.C. ; Sadikin-Susilo
Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The Journal of International Medical Research vol. 40 no. 05 (Sep. 2012), page 1654-1661.
Topik: Hepatocellular Carcinoma; Immunohistochemical Analysis; Interferon-Alpha; Interferon-Gamma; Interleukin-33
Ketersediaan
  • Perpustakaan FK
    • Nomor Panggil: J11.K
    • Non-tandon: 1 (dapat dipinjam: 0)
    • Tandon: tidak ada
    Lihat Detail Induk
Isi artikelOBJECTIVE: To study the clinical significance of intercellular interleukin (IL)-33 in hepatocellular carcinoma (HCC). METHODS: Using immunohistochemistry, this prospective study compared IL-33 protein levels in samples of HCC tissue and normal tissue adjacent to the tumour in 60 patients with HCC, and in normal liver tissue from six healthy controls. Interferon (IFN)-a, IFN-? and IL-33 serum levels were also analysed by enzyme-linked immunosorbent assay in HCC 30 patients and 10 healthy controls. The level of IL-33 immunohistochemical staining was compared with the rate of lymph node metastasis in HCC patients. RESULTS: IL-33 was strongly positive in the cytoplasm of hepatocytes. The median percentage of IL-33-positive tissue was higher in HCC than in normal liver tissue samples (adjacent to the tumour or from controls). Serum IFN-a, IFN-? and IL-33 levels were higher in pre- and postoperative samples from HCC patients than in control samples, and in patients with metastasis compared with those without metastasis. CONCLUSIONS: Increased IL-33 protein levels were observed in serum and liver tissue from HCC patients; IL-33 may be a useful biological marker for monitoring HCC growth and metastasis.
Opini AndaKlik untuk menuliskan opini Anda tentang koleksi ini!

Kembali
design
 
Process time: 0.015625 second(s)